Probiotic treatment for women with fertility disorders
Official title: A Randomized, Double-blind, Placebo-controlled Study to Confirm the Positive Effect of Fertibiome® (Ligilactobacillus Salivarius PS11610) on the Female Genital Tract Microbiota of Couples or Women With Fertility Disorders.
Run by ProbiSearch SL · NCT06122207 · Data updated 2026-11-12
This study is testing whether a probiotic called Fertibiome® can help improve fertility for women and couples dealing with fertility issues by restoring a healthy vaginal microbiome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | ProbiSearch SL Industry-sponsored |
| Locations | 2 sites (Lisbon and 1 other locations) |
| Status | Recruiting |
| Started | February 14, 2024 |
| Main results expected | December 2026 |
| Study ends | March 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06122207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women aged 18 to 40 and men aged 18 to 55 who are experiencing fertility disorders and are undergoing or planning to undergo IVF treatment.
✕Probably not a fit
Patients who do not have a fertility diagnosis or those with significant chronic health issues or high BMI may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of the probiotic product Fertibiome® on the vaginal microbiota of women and couples experiencing fertility disorders. It is a randomized, double-blind, placebo-controlled trial that aims to determine whether restoring a healthy vaginal microbiome can improve fertility outcomes. Participants will take the probiotic or a placebo for approximately six months, with the study focusing on those undergoing assisted reproductive treatments. The research is based on the premise that a healthy urogenital microbiome can enhance implantation rates and pregnancy success.
Why it matters
Potential benefit: If successful, this study could improve fertility outcomes for women with dysbiosis and enhance the effectiveness of assisted reproductive treatments.
How similar studies have gone: Previous studies have indicated positive outcomes with probiotic treatments for restoring vaginal microbiota, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Couples or women with ages between 18 and 45 for woman and between 18 and 55 for man (in case of couple participation). * Couples or women with fertility disorders. * Couples or women undergoing IVF treatment or willing to start it. * Signature of the Informed Consent. Exclusion Criteria: * Women, not participating in the study with a couple, who have not undergone at least 4 cycles of artificial insemination with donor's sperm (AID) or 1 cycle of IVF without achieving evolutionary pregnancy. * Women with Body Mass Index (BMI) ≥ 30. * Couples where the woman has not infertility diagnosis while the man has any of the following characteristics: * Azoospermia * Sperm motility (A + B) \< 25%. * Sperm morphology ≤ 2%. * Vas deferens obstruction. * Couples or women with any of the following characteristics: * Chronic diseases that cause intestinal malabsortion. * Congenital or acquired immunodeficiency. * Current history or diagnosis of alcohol, tobacco, or drug abuse. * Uncertainty about the willingness or ability of participants to comply with the requirements of the protocol. * Under treatment with probiotics during the last week.
Where it's running
-
Dr. Miguel Raimundo (Portugal)
Lisbon, Portugal Recruiting -
Hospital Universitario La Paz
Madrid, Madrid, Spain Recruiting
Study contacts
- Study coordinator: Susana Manzano Jiménez, PhD
- Email: susana.manzano@probisearch.com
- Phone: 918035179
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Developing an AI tool to predict embryo quality from time‑lapse incubator images
This project will test an AI program that analyzes time‑lapse embryo images to help embryologists identify higher‑quality embryos for people having IVF or egg‑freezing.
-
Menopur and Rekovelle combination for personalized ovarian stimulation
This test will see if starting Rekovelle and Menopur doses set by a woman's age and weight work as well as doses set by AMH and weight for women aged 18–40 having IVF.
-
Comparing sperm selection methods for intrauterine insemination
This study is testing two different ways to prepare sperm for couples trying to get pregnant through intrauterine insemination to see which method leads to more successful pregnancies.
-
Freezing testicular tissue to help preserve fertility in young boys with cancer
This study tests if freezing testicular tissue from young boys with cancer can help them preserve their ability to have children later on.
-
Evaluating Fertility Treatments in Women with Rheumatic Diseases
This study is trying to see how well fertility treatments work for women with rheumatic diseases and if these treatments affect their health conditions.
-
Investigating ovarian tissue cryopreservation in girls with Turner syndrome
This study is testing if freezing ovarian tissue can help girls with Turner syndrome have babies later in life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.